Abbott

ReVolt Against the Ordinary

Reengineering PFA with the fewest applications1 and total control

This device is commercially available for use in select international markets.

References

  1. Tilz, R.R. (2025, January 17) Acute results demonstrate safety and effectiveness of balloon-based pulsed field ablation system for de novo PVI in PAF and PersAF [Late Breaking Presentation]. AF Symposium 2025, Boston MA, USA.

Banner 4

Banner 5

Banner 6

Banner 7

Banner 8

Banner 9

Banner 10

Banner 11

MAT-XXXXXXX